FAKDX | VIVIX | FAKDX / VIVIX | |
Total Expense Ratio | 1.22 | 0.04 | 3,050% |
Annual Report Gross Expense Ratio | 1.22 | 0.04 | 3,050% |
Fund Existence | 17 years | 27 years | - |
Gain YTD | 3.725 | 3.760 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 92.7M | 195B | 0% |
Annual Yield % from dividends | 1.85 | 2.19 | 85% |
Returns for 1 year | -0.25 | 5.70 | -4% |
Returns for 3 years | 18.62 | 28.41 | 66% |
Returns for 5 years | 42.52 | 70.38 | 60% |
Returns for 10 years | 36.07 | 110.24 | 33% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HLFZX | 8.90 | 0.03 | +0.34% |
Harding Loevner Frontier Emerg MktsInstZ | |||
BRXRX | 15.18 | -0.11 | -0.72% |
MFS Blended Research Intl Eq R1 | |||
MSBVX | 11.82 | -0.10 | -0.84% |
Morgan Stanley American Resilience I | |||
IUAAX | 42.88 | -0.41 | -0.95% |
VY® Invesco Equity and Income A | |||
HFMRX | 30.14 | -0.43 | -1.41% |
Hartford MidCap R3 |